Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 2/2020

01-03-2020 | IM-Point of view

WhatsApp and other messaging apps in medicine: opportunities and risks

Authors: Marco Masoni, Maria Renza Guelfi

Published in: Internal and Emergency Medicine | Issue 2/2020

Login to get access

Abstract

WhatsApp is a popular messaging application frequently used by physicians and healthcare organizations that can improve the continuity of care and facilitate effective health services provision, especially in acute settings. However WhatsApp does not comply with the rules of the European GDPR and the US HIPA Act. So it is inappropriate to share clinical information via WhatsApp.
For this reason alternatives to Whatsapp are considered. In particular, the features that must have secure messaging apps to be in compliance with GDPR and HIPAA and to protect patient data will be discussed. The aim is to encourage healthcare organizations and physicians to abandon WhatsApp and to adopt one of the many secure messaging apps now available, some of them at no cost.
Literature
1.
Johnston MJ, King D, Arora S, Behar N, Athanasiou T, Sevdalis N, Darzi A (2015) Smartphones let surgeons know WhatsApp: an analysis of communication in emergency surgical teams. Am J Surg 209(1):45–51CrossRef
2.
Astarcioglu MA, Sen T, Kilit C, Durmus HI, Gozubuyuk G, Kalcik M et al (2015) Time-to reperfusion in STEMI undergoing inter hospital transfer using smartphone and WhatsApp messenger. Am J Emerg Med 33(10):1382–1384CrossRef
3.
De Benedictis A, Lettieri E, Masella C, Gastaldi L, Macchini G, Santu C et al (2019) WhatsApp in hospital? An empirical investigation of individual and organizational determinants to use. PLoS ONEne 14(1):e0209873CrossRef
4.
John B (2018) Are you ready for General Data Protection Regulation? BMJ 360:k941CrossRef
5.
6.
Calleja-Castillo JM, Gonzalez-Calderon G (2018) WhatsApp in stroke systems: current use and regulatory concerns. Front Neurol 9:388CrossRef
7.
8.
Thomas K (2018) Wanted: a WhatsApp alternative for clinicians. BMJ 360:k622CrossRef
9.
Bergeron D, Iorio-Morin C (2019) In reply to the letter to the editor "other apps beyond WhatsApp". World Neurosurg 130:568CrossRef
10.
Metadata
Title
WhatsApp and other messaging apps in medicine: opportunities and risks
Authors
Marco Masoni
Maria Renza Guelfi
Publication date
01-03-2020
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 2/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-020-02292-5

Other articles of this Issue 2/2020

Internal and Emergency Medicine 2/2020 Go to the issue

IM - COMMENTARY

Cost-effectiveness analysis of different hypertension management strategies

EM - ORIGINAL

Risk stratification of patients with chest pain or anginal equivalents in the emergency department

IM - COMMENTARY

Female sex and stroke in atrial fibrillation: an intriguing relationship

CE-Systematic reviews and meta-analysis

Acute kidney injury and vancomycin/piperacillin/tazobactam in adult patients: a systematic review

CE - LETTER TO THE EDITOR

Handling shock in idiopathic systemic capillary leak syndrome (Clarkson's disease) less is more: reply

IM - REVIEW

Stigmatisation and resilience in inflammatory bowel disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits